RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis

MLA

Philip C. Hoffman, et al. “RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis.” Journal of Thoracic Oncology, vol. 16, Jan. 2021, p. S45. EBSCOhost, https://doi.org/10.1016/j.jtho.2020.10.089.

APA

Philip C. Hoffman, Aditya Juloori, K.B. Pointer, Christine M. Bestvina, Sean P. Pitroda, Steven J. Chmura, Michael J. Jelinek, Everett E. Vokes, & Jyoti D. Patel. (2021). RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis. Journal of Thoracic Oncology, 16, S45. https://doi.org/10.1016/j.jtho.2020.10.089

Chicago

Philip C. Hoffman, Aditya Juloori, K.B. Pointer, Christine M. Bestvina, Sean P. Pitroda, Steven J. Chmura, Michael J. Jelinek, Everett E. Vokes, and Jyoti D. Patel. 2021. “RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis.” Journal of Thoracic Oncology 16 (January): S45. doi:10.1016/j.jtho.2020.10.089.